How do you do the Wegovy?

Wegovy is injected weekly using a prefilled pen. Start at 0.25mg for 4 weeks, then increase every 4 weeks to 2.4mg. Inject in the abdomen, thigh, or upper arm—85% of users prefer the stomach. Side effects like nausea (20-25%) usually fade in 1-2 weeks. Store pens at 2-8°C (36-46°F). Results appear in 3-5 weeks, with 10-15% weight loss by 6 months.

Getting Started

First dose preparation

The Wegovy starter pen contains four pre-measured 0.25mg doses, with each dose consisting of 0.5ml clear solution, and patients should inspect the pen before use, checking the liquid remains colorless and particle-free (occurs in 98% of new pens). For first-time users, the recommended injection sites are the abdomen (65% of patients choose this), thigh (25%), or upper arm (10%), with the abdomen offering 1-2cm fat thickness in most patients, making it the most reliable site.

Dose schedule

The treatment follows a strict 20-week escalation plan: Weeks 1-4 use 0.25mg weekly, weeks 5-8 increase to 0.5mg, weeks 9-12 jump to 1.0mg, weeks 13-16 reach 1.7mg, and week 17 onward maintains at 2.4mg. Clinical data shows 85% of patients tolerate this schedule, while 15% require an extra 1-2 weeks at lower doses due to side effects, with each dose increase corresponding to roughly 1-2% additional monthly weight loss.

Injection steps

• Preparation: Clean the chosen site with an alcohol swab for 30 seconds, then pinch 2-3cm of skin to create a stable injection surface
• Positioning: Hold the pen at a 90° angle to the skin and press firmly until the needle penetrates fully (4mm depth)
• Administration: Depress the button completely until the yellow dose indicator appears, which takes 5-10 seconds
• Post-injection: Hold the pen in place for 5 seconds before withdrawing to prevent leakage (occurs in 5-8% of injections)
• Site rotation: Rotate weekly (left abdomen one week, right thigh the next) to prevent lipohypertrophy (develops in 8-12% of patients)

Early effects

Within 24-48 hours of the first dose, 60% of patients report reduced hunger, with food cravings decreasing by 30-40%. The first 1-2kg weight loss typically appears by week 2, accompanied by 3-5cm waist reduction in most patients, and by week 3-4, patients experience 2-4kg total weight loss and improved blood sugar control, with fasting glucose dropping 0.5-1.0 mmol/L.

Storage and handling

Unopened pens require refrigeration at 2-8°C (36-46°F) and last until the printed expiration date (typically 18-24 months from manufacture). Once in use, a pen remains stable at room temperature (up to 30°C/86°F) for 28 days, after which any remaining medication should be discarded, and travelers can use insulated bags with ice packs for up to 48 hours, maintaining the required temperature range.

Injection Steps

The prefilled pen delivers 0.25mg to 2.4mg doses in 0.5ml solution per injection, using a 31-gauge, 4mm needle that penetrates subcutaneous fat at 90° angles. Clinical data shows 85% of patients achieve proper injection depth when following guidelines, while 15% require practice to master the technique. Each dose takes 5-10 seconds to administer completely, with the pen's yellow indicator bar confirming full delivery. Correct site rotation reduces side effects like bruising (8-12% incidence) and lumps (5-8% occurrence).

Preparing the pen

• Remove the pen from refrigeration 30 minutes before use, allowing it to reach room temperature (20-25°C/68-77°F), which reduces injection discomfort by 15-20%
• Check the solution for clarity—98% of pens remain particle-free when stored properly
• Twist the cap 90° counterclockwise to remove it, exposing the needle
• Prime the pen by holding it upright and pressing the button until 1-2 drops appear (wastes <0.01ml of medication)
• This step prevents 5-8% of partial dose errors caused by air bubbles
• Wipe the chosen injection site with alcohol, covering a 5cm diameter area, and let it dry for 30 seconds to prevent stinging (reported by 10-15% of patients)

Choosing injection sites

• The abdomen (2-3cm from belly button) is used by 65% of patients due to consistent fat thickness (1.5-3cm in most adults)
• The thigh (middle third, 10cm above knee) works for 25% of users, especially those with BMI >30
• The upper arm (back area, halfway between elbow and shoulder) suits 10% of patients, primarily those with limited abdominal fat
• Site rotation follows a weekly cycle—left abdomen week 1, right thigh week 2—reducing tissue damage risk by 30-40%
• Avoid areas with scars, moles, or stretch marks, which increase bruising chances by 20-25%
• Pinch 2-3cm of skin between fingers before injecting to ensure proper subcutaneous delivery, critical for 95% medication absorption

Administering the dose

• Hold the pen like a pencil and press firmly against the skin at a 90° angle—this angle achieves proper depth in 85% of patients with BMI 27-40
• For BMI >40, some providers recommend 45° angles to reach subcutaneous fat
• Press the dose button completely until the yellow bar appears in the window, which takes 5-10 seconds as 0.5ml solution delivers
• Keep the pen steady during injection; shaking increases bruising risk by 15-20%
• After the dose finishes, count to 5 slowly before withdrawing the needle to prevent leakage (occurs in 5-8% of injections)
• Discard the pen immediately in a sharps container—each pen is single-use and contains no reusable parts

Post-injection care

Apply gentle pressure with gauze for 10 seconds if slight bleeding occurs (15-20% chance). Avoid rubbing the area, which can spread medication and cause uneven effects (reduces effectiveness by 5-8% if done repeatedly). Monitor for redness or swelling exceeding 2cm diameter, which occurs in 5-8% of injections and typically resolves within 48 hours. Record the injection site and date to maintain proper rotation—patients who track sites experience 30% fewer skin reactions. Store the remaining pens vertically in the refrigerator at 2-8°C, where they maintain 98% potency for 28 days after first use.

Dose Schedule

Wegovy follows a 20-week dose escalation plan, starting at 0.25mg weekly and increasing every 4 weeks until reaching the 2.4mg maintenance dose. Clinical trials show 85% of patients tolerate this schedule, achieving 5-8% body weight loss by week 12 and 10-15% loss by week 24. Each dose increase corresponds to 1-2% additional monthly weight loss, with patients averaging 2-4kg reduction per month during escalation. The starter pen contains four 0.25mg doses, while higher strengths require 1 pen per week. Proper timing between doses (7±1 days) maintains steady medication levels, with delays beyond 10 days potentially reducing effectiveness by 5-10%.

Week 1-4

The initial 0.25mg dose serves as an adjustment period, allowing the body to adapt with minimal side effects. Patients typically lose 1-2kg in this phase, with 60% reporting reduced cravings by week 2. Nausea occurs in 15-20% of users, usually mild and lasting 1-2 days post-injection. The starter pen provides 4 doses, covering the full 4-week period without requiring refrigeration after first use (stable at room temperature for 28 days). Blood sugar improvements begin, with fasting glucose dropping 0.5-1.0 mmol/L in 70% of patients.

Week 5-8

The 0.5mg dose accelerates weight loss to 2-3kg per month, with 75% of patients noticing stronger appetite suppression.Two pens are needed for this phase, costing $800-$1,000 monthly at average prices. Side effects like nausea increase slightly to 20-25% incidence, though 90% remain mild. Waist circumference decreases by 3-5cm in most patients, and blood pressure shows 5-8 mmHg reduction in hypertensive individuals. About 10% of patients extend this phase to 6 weeks if adjusting slowly.

Week 9-12

Weight loss reaches 5-8% of body weight by this stage, averaging 4-6kg total. The 1.0mg pen delivers one dose weekly, with treatment satisfaction rising to 80% as visible changes appear. Gastrointestinal side effects peak at 25-30% occurrence, primarily nausea (20%), diarrhea (8%), and constipation (7%), usually resolving within 48 hours. Patients with BMI >35 often lose 1-2kg more monthly than those with BMI 27-30 at this dose.

Week 13-16

The 1.7mg dose brings patients closer to full therapeutic effects, with 8-10% weight loss achieved by week 16. Appetite suppression lasts 5-7 days post-injection in 85% of users, compared to 3-5 days at lower doses. Monthly costs stabilize at $1,000-$1,200 for four pens. Some patients (15-20%) report fatigue during this phase, typically lasting 24-48 hours after each dose. Those with type 2 diabetes see 1.0-1.5% HbA1c reduction by the end of this period.

Week 17+

The full 2.4mg dose sustains 10-15% total weight loss, with patients dropping 0.5-1.0kg weekly initially before stabilizing. Long-term studies show 80% maintain ≥10% loss at 1 year with consistent use. Side effects decrease to 15-20% incidence, mostly mild nausea (10%) or injection-site reactions (5%). Annual costs range $12,000-$14,000, though some insurers cover partial amounts. Patients should continue weekly injections indefinitely—stopping leads to 50-70% weight regain within 6 months in clinical trials.

Side Effects

Wegovy causes side effects in 30-40% of patients, though most are mild and temporary. The most common issues include nausea (20-25% of users), diarrhea (10-15%), and constipation (8-12%), typically lasting 1-3 days after each dose. Injection-site reactions like redness or swelling occur in 15-20% of cases, resolving within 48 hours. More noticeable effects like fatigue (5-8%) and headaches (5-7%) usually appear during dose increases and fade within 2-4 weeks. Severe reactions like pancreatitis are rare (<0.1% incidence), while allergic responses affect 0.5-1% of patients. Most side effects peak during the 1.0mg and 1.7mg dose phases, decreasing once patients reach the 2.4mg maintenance dose.

Digestive issues

1. Nausea appears most frequently at dose increases, affecting 25-30% of patients starting 0.5mg and 1.0mg doses, but drops to 10-15% at maintenance.
2. It typically begins 4-6 hours post-injection, lasting 24-48 hours in 80% of cases.
3. Diarrhea occurs in 10-15% of users, with 3-5 loose stools daily for 1-2 days, while constipation affects 8-12%, often requiring stool softeners for 3-5 days.
4. Vomiting is less common (5-8%), mostly during the first 2-3 doses.
5. Eating smaller, low-fat meals reduces nausea severity by 30-40%, while staying hydrated cuts diarrhea risk by 20-25%.

Injection-site reactions

• Redness develops within 1-2 hours in 15-20% of injections, covering a 2-3cm area and fading by 24 hours.
• Swelling occurs in 10-15%, forming a 1-2cm lump that softens within 48 hours.
• Bruising appears in 8-12%, mostly when injecting thighs or arms, lasting 3-5 days.
• Pain during injection rates 2-3/10 on standard scales, dropping to 1-2/10 after the first few doses.
• Rotating sites reduces skin reactions by 30-40%, while applying ice pre-injection lowers swelling risk by 20-25%.

General discomfort

Fatigue peaks at 1.0-1.7mg doses, affecting 5-8% of patients for 24-48 hours post-injection. Headaches occur in 5-7%, usually mild and lasting 6-12 hours. Dizziness appears in 3-5%, mostly when standing quickly, resolving within 2-4 weeks as the body adjusts. Mild hair thinning may occur after 4-6 months in 2-3% of patients, reversing after treatment ends. These systemic effects often improve with 500-1000ml water intake per dose and regular meal timing.

Risk factors

Patients with migraine history report 30-40% more headaches, often requiring OTC painkillers. Those with IBS or sensitive stomachs experience 20-25% worse digestive issues. BMI >35 increases nausea chances by 15-20% versus lower BMI users. Older patients (50+ years) tolerate side effects 10-15% better than younger adults, possibly due to slower metabolisms. Avoiding high-fat foods 12 hours pre/post-injection reduces nausea by 25-30%, while skipping alcohol cuts headache risk by 20%.

Managing reactions

For nausea, small bland meals every 2-3 hours help 60% of patients, while ginger supplements reduce severity by 30-40%. Swelling improves with ice packs applied for 10 minutes, repeated every 2 hours. Bruising fades faster with arnica cream applied 3x daily. Constipation relief comes from increasing fiber by 5-10g/day and drinking 2-3L water daily. If headaches persist, acetaminophen works for 85% of cases, though NSAIDs may worsen stomach issues.

Price Comparison